The pharmacokinetics of diminazene in five female Boran (Bos indicus) cattle before and then during acute and chronic phases of experimental infections with Trypanosoma congolense were investigated. A 7.0% (wt/vol) solution of diminazene aceturate (Berenil) was used in all three phases of the study and administered as a single intramuscular dose of 3.5 mg of diminazene base per kg of body weight. There were no significant differences between the values of pharmacokinetic parameters for the noninfected cattle and the values for cattle with a chronic T. congoknse infection. However, the maximum concentration of the drug in plasma during the acute phase of infection (8.25 1.72 ,ug/ml) was significantly (P < 0.01) greater than that during chronic infection (5.04 0.26 ,ug/ml) and that in the noninfected state (4.76 0.76 ,Ig/mI). Similarly, the time to maximum concentration of the drug in plasma when diminazene was administered during the acute phase of infection (18.00 6.71 min) was significantly (P < 0.02) shorter than that for noninfected cattle (36.00 + 8.22 min) and that during chronic infection (33.75 + 7.50 min). The volume of distribution at steady state during acute infection (1.01 + 0.31 liter/kg) was significantly (P < 0.01) smaller than that in the noninfected state (1.37 + 0.17 liter/kg) and that in chronic infection (1.51 + 0.24 liter/kg). Eight hours after the drug had been administered, the concentration-time data profiles for each of the three study phases were very similar. Mean concentrations of diminazene in plasma 48 h after administration of the drug were 0.43 0.07 ,ug/ml in noninfected cattle, 0.43 0.11 ,ug/ml during the acute phase of trypanosome infection, and 0.44 + 0.09 ,ug/ml during the chronic phase of the infection. Results of the present study indicate that the area under the concentration-time curve for diminazene in trypanosome-infected cattle did not differ significantly from that for noninfected cattle. It, therefore, appears that the total amount of diminazene attained and maintained in the plasma of cattle is not significantly altered during infection with T. congolense.
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The compound 1,3-bis(4-amidinophenyl)triazene diaceturate tetrahydrate (7, 14) , marketed as Berenil, Ganaseg, and Veriben, is known to have high therapeutic efficacy against a wide range of members of the families Trypanosomatidae and Babesidae (10) . For treatment of Trypanosoma congolense and Trypanosoma vivax infections in domestic livestock, the recommended dose is 3.5 mg of diminazene aceturate per kg of body weight (b.w.), administered intramuscularly (i.m.) on one occasion. However, while the single dose is usually curative, relapses are known to occur following treatment (21, 27) . These are generally attributed either to innate parasite resistance to diminazene or to reinvasion of the peripheral circulatory system by trypanosome populations sequestered in sites believed to be inaccessible to diminazene, such as the central nervous system (20) .
The pharmacokinetics of diminazene have been documented for cattle (2, 23, 24) , rabbits (18) , goats (5) , and sheep (4). However, the effect of a trypanosome infection on the pharmacokinetics of diminazene has been described only for rats (38) , rabbits (19) , and dogs (35) . Since such information would have implications for the therapeutic regime used for cattle, the present study was conducted to determine whether the pharmacokinetics of diminazene in noninfected cattle differ significantly from those in cattle with an acute or chronic infection of T. congolense. (22) and found to be negative for antibodies to Trypanosoma, Theileria, Babesia, and Anaplasma species. Throughout the duration of the study, the animals were kept under fly-proof conditions and fed hay and water ad libitum. They were also fed a concentrate ration (Young stock [300 to 400 g per animal per day]; Belfast Millers, Nairobi, Kenya).
MATERUILS AND METHODS

Experimental
Trypanosomes and infection of cattle. T. congolense IL 1180 is a doubly cloned derivative (31) of an isolate collected from a lion in the Serengeti National Park, Tanzania (15) . T. congolense IL 2642 is a doubly cloned derivative (37) of an isolate collected from a cow in Busoga, Uganda (29) . Previous studies have shown that when cattle are infected with a population of T. congolense and the infection is eliminated with a trypanocide, variant-specific antibody responses are elicited and confer protection against homologous challenge for S months (1). Thus, T. congolense IL 1180 and T. congolense IL 2642 were used in the study described here, since they are antigenically unrelated (36) . In order to infect cattle, the numbers of trypanosomes were expanded in sublethally irradiated (650 rads) mice. During the first peak of parasitemia, mice were exsanguinated by cardiac puncture and the blood was collected into sodium citrate (final concentration, 1.0%, wt/vol) to prevent clotting. The blood was pooled and diluted in phosphate-saline-glucose (pH 7.4), and the number of trypanosomes was determined with a Neubauer hemocytometer. The cattle were then infected by intravenous inoculation of 1.0 x 107 trypanosomes per animal. Starting a week prior to initiation of each infection and until 30 days after each treatment, the PCV was determined daily. During the same period, rectal temperature and level of parasitemia (30) were also monitored on a daily basis.
Collection of blood and quantification of diminazene. During each phase of the study, blood was collected at various time intervals (0, 5, 10, 15, 30, and 45 min and 1, 1.5, 2, 3, 4, 6, 8, 10, 12, 14, 16, 18, 21, 24, 30, 36 , and 48 h) following administration of the drug. The methods of blood collection, plasma separation and storage, paired-ion extraction of diminazene from the plasma, and quantification of diminazene in the resultant extract using high-performance liquid chromatography were previously described (2, 3). The limit of detection of the technique is 10 ng of diminazene per ml. Over the concentration range consisting of 0.010, 0.05, 0.10, 0.25, 0.50, 1.00, 2.50, 5.00, and 10.00 ,ug/ml, the response of diminazene was linear (r2 = 0.997). Mean (2) . Repeated-measures analysis of variance was used to determine the statistical significance of differences between the means of the pharmacokinetic parameters estimated for the three phases of the study; P values less than or equal to 0.05 were considered significant. Statistically significant differences based on the analysis of variance were further evaluated by the Tukey-Kramer method to make pairwise comparisons among means. All statistical analyses were conducted by using the statistical software package Minitab 
RESULTS
Plots of the mean values of the concentration-time data for diminazene in plasma for each of the three phases of the study are shown in Fig. 1 cattle and those with a chronic T. congolense infection. There were also no significant differences between noninfected cattle and those chronically infected with T. congolense in the values of all absorption, distribution, and elimination pharmacokinetic parameters that were determined (Tables 1 to 3 ). Furthermore, 8 h after the drug had been administered, the mean concentration-time data profiles for each of the three study phases were very similar (Fig. 1) . Mean concentrations of diminazene in plasma 48 h after administration of the drug were 0.43 ± 0.07 ,ug/ml in noninfected cattle, 0.43 + 0.11 ,ug/ml in the acute phase of trypanosome infection, and 0.44 ± 0.09 ,ug/ml in the chronic phase of infection.
Values of the pharmacokinetic parameters estimated through compartmental and noncompartmental analyses are summarized in Tables 1 to 3 . Of these parameters, Vss during acute infection (1.01 ± 0.31 liter/kg) was significantly (P < 0.01) smaller than that in the noninfected state (1.37 ± 0.17 liter/kg) and that during chronic infection (1.51 ± 0.24 liter/kg). The volume of the central compartment did not differ significantly between the noninfected and trypanosome-infected states. The zero time intercept of the second distribution phase during acute infection (4.97 ± 2.28 ,ug/ml) was significantly (P < 0.05) greater than that in the chronic state (2.06 ± 0.29 ,ug/ml) and that in the noninfected state (2.26 + 0.50 ,ug/ml). In addition, the transfer rate from the shallow peripheral compartment to the central compartment in noninfected cattle (0.39 + 0.10 h-') was significantly (P < 0.05) slower than that during acute infection (0.77 + 0.29 h-1). Finally, there were no significant differences between the three phases with respect to AUC, AUMC, mean residence time, or total body clearance ( Table 1) .
The temperature at the time of treatment during acute infection (40.2 ± 0.4°C) was significantly (P < 0.05) greater than that in the noninfected cattle (38.6 ± 0.2°C) and that in cattle at the time of treatment during chronic infection (38.2 ± 0.5°C). Following treatment of acute and chronic infections, all cattle became aparasitemic within 24 h of drug administration and remained aparasitemic throughout the 30-day observation period following treatment. (23, 24) . Despite their similarity to those in previous studies, however, values of parameters determined in the present study were associated with rather wide confidence intervals. But since diminazene has a long elimination t1/2 (23, 24) , it would appear that some of these parameters may be more precisely estimated by analysis of concentration-time datum points beyond the 48 h used in the present study.
DISCUSSION
In a previous study (2), it was reported that i.m. administration of diminazene as the diaceturate salt to noninfected cattle (same breed and sex as those used in the present study) was followed by rapid absorption of the drug and showed a similar plasma Cm. (4.68 ± 1.12 p,g of diminazene Since the trypanocidal activity of diminazene is dependent 1+1+1+ z z w_ vD jon uptake of the molecule by trypanosomes (9, 26, 
